Generic FDC drug vs two monoproduct drug or vs "originator" FDC drug? [Design Issues]

posted by Beholder  – Russia, 2018-09-04 11:12 (1149 d 01:30 ago) – Posting: # 19234
Views: 3,402

Hello to everybody!

There is generic FDC drug named AB which is intended to be studied in BE study. There are two options to choose reference drug (s) for that study:
1. two separate monoproducts - named drug A and drug B. Both drugs considered as reference drugs
2. "original" FDC drug named AB which is also considered as reference drug.
Which drug (s) to choose as reference drug (s)? What would be your opinion?
THX in advance.

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,545 registered users;
online 15 (0 registered, 15 guests [including 7 identified bots]).
Forum time: Wednesday 12:42 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5